Leo Cancer Care: Funding, Investors & Team (Oct 2026)
Leo Cancer Care provides a streamlined and effective treatment method that empowers patients and instills hope. Founded in Australia, Leo Cancer Care is grounded in international research on the advantages of upright patient positioning. Through a shift from machine rotation to patient rotation, Leo Cancer Care is positioned to revolutionize radiation therapy.
Leo Cancer Care has raised $130M across 4 funding rounds on record, the most recent a Series D of $65.0M announced in Jul 2026.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Leo Cancer Care Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Leo Cancer Care Funding Rounds
1 of 4 rounds was announced without a disclosed amount and is excluded from the total.
Leo Cancer Care raised $25.3M in a Series B announced in Jul 2021.
2.9 years later, a Series C was announced in Jun 2024 with no disclosed amount.
1.3 years later, an undisclosed round of $40.0M was announced in Sep 2025.
10 months later, a Series D of $65.0M was announced in Jul 2026.
Leo Cancer Care Investors
16 investors are recorded in total; the 5 named above are those the record identifies.
Leo Cancer Care Founders and Leadership Team
Contact details for the Leo Cancer Care team: 1 of 2 have an email address on file.
Start 14-day free trial →Leo Cancer Care Funding Compared to Other Health Care Startups
Leo Cancer Care's latest round of $65.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Leo Cancer Care in Health Care and Harley
Companies Similar to Leo Cancer Care
We are pioneering the use of semiconductor technology for next-generation neural implants. Our mission is to…
52 North Health intends to further develop medical services with a clinical gadget that utilizes man-made…
SageTech is recycling inhalational anaesthetic agents using patented technology to generate significant cost…
Renata Medical develops purposeful medical devices for unmet pediatric needs.
Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous…
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Nebu-Flow is a manufacturer of the next generation of inhaled drugs for patients with respiratory disorders.…
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial…
Innovative medical gadgets are created by Creo Medical Limited, situated in Chepstow, South Wales. With a…
TympaHealth has developed the world's first ear and hearing health assessment system. The Tympa system…
NEX Health Intelligence (NEX) is a health-tech business that develops AI-powered software for hospitals to…
Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.
Leo Cancer Care Funding FAQs
What does Leo Cancer Care do?
Leo Cancer Care provides a streamlined and effective treatment method that empowers patients and instills hope. Founded in Australia, Leo Cancer Care is grounded in international research on the advantages of upright patient positioning. Through a shift from machine rotation to patient rotation, Leo Cancer Care is positioned to revolutionize radiation therapy.
How much funding has Leo Cancer Care raised?
Leo Cancer Care has raised $130M across 4 rounds on record. The most recent is a Series D of $65.0M announced in Jul 2026.
When did Leo Cancer Care last raise funding?
Leo Cancer Care's most recent funding round on record is a Series D of $65.0M, announced in Jul 2026.
Who has invested in Leo Cancer Care?
Investors on record for Leo Cancer Care include Alumni Ventures, Catalio Capital Management, Serra Ventures, EDBI, Yu Galaxy. FundedIQ records 16 investors in total.
Who founded Leo Cancer Care?
FundedIQ lists Stephen Towe (Founder) at Leo Cancer Care.
Where is Leo Cancer Care headquartered?
Leo Cancer Care is based in Harley, Surrey, United Kingdom.
How many employees does Leo Cancer Care have?
Leo Cancer Care is in the 51-100 employee band.
When was Leo Cancer Care founded?
Leo Cancer Care was founded in 2016.
How does Leo Cancer Care's funding compare to other Health Care startups?
Leo Cancer Care's latest round of $65.0M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Leo Cancer Care Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Leo Cancer Care is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.